BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 12, 2022 11:26am

160 Views

Post# 35019627

BIOV NO COMPLAINTS QUARTER MILLION VOLUME BEFORE LUNCH!

CHART...absolutely no complaints. Welcome welcome to all retail who have found BIOV.

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

11:22:49 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	5.0	0.185	·	0.195	5.0	0.19	-0.03	-13.6	222.2	39	70	0.22 0.22 0.17	0.465 0.085	10:47:21	Oct 06	15 min RT 2¢
CSE - C	5.0	0.185	·	0.195	5.0	0.19	-0.03	-13.6	123.9	22	35	0.22 0.22 0.17	0.465 0.085	10:47:21		15 min
NEO ATS - U						0.185	-0.035	-15.9	57.5	10	16	0.21 0.21 0.17		10:46:25		15 min
Omega - O						0.185	-0.035	-15.9	39.5	7	9	0.19 0.20 0.185		10:46:25		15 min
CXD - D						0.22			0.1		2			Jul 04		15 min
TriAct - M						0.22			1.2		8					15 min